ABL1, Polyclonal Antibody Pair

Tyrosine-protein kinase ABL1; Abelson murine leukemia viral oncogene homolog 1; Abelson tyrosine-protein kinase 1; Proto-oncogene c-Abl; p150; ABL1; ABL; JTK7

For Research Use Only. Not for use in diagnostic procedures.

Polyclonal

Capture: IgG
Detection: IgG

Capture: Rabbit
Detection: Rabbit

Liquid

The concentrations and volumes of the antibodies may vary and be lot specific. Details will be on the vial labels. (lot specific)

Upon delivery aliquot and store at -20 degree C or -80 degree C. Avoid repeated freeze/thaw cycles. When stored properly, products should be stable for at least 5 months.

Manufactured in an ISO 13485:2003 and EN ISO 13485:2012 Certified Laboratory.

Small volumes of ABL1 antibody pair vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Sandwich ELISA (EIA)

We recommend using the capture antibody at a concentration of 0.1ug/ml and the detection antibody at a concentration of 0.1ug/ml.

124,955 Da

ABL proto-oncogene 1, non-receptor tyrosine kinase

tyrosine-protein kinase ABL1

Tyrosine-protein kinase ABL1

ABL; JTK7  [Similar Products]

ABL1_HUMAN

This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons. [provided by RefSeq, Aug 2014]

Abl: an ubiquitously expressed and highly conserved proto-oncogenic tyrosine kinase. c-Abl protein is distributed in both the nucleus and the cytoplasm of cells. Negatively regulated by its SH3 domain, and deletion of the SH3 domain turns ABL1 into an oncogene. It has been implicated in regulation of cell proliferation, differentiation, apoptosis, cell adhesion and stress response. The Philadephia chromosome translocation t(9;22)(q34;q11) creates a Bcr-Abl fusion protein, responsible for 90% of chronic myelogenous leukemia (CML) and ~25% of acute lymphoblastic leukemia (ALL). Inhibitors: Gleevec (imatinib, Glivec), Dasatinib. Two alternatively-spliced isoforms have been described.

Protein type: Abl family; EC 2.7.10.2; Kinase, protein; Oncoprotein; Protein kinase, TK; Protein kinase, tyrosine (non-receptor); TK group

Chromosomal Location of Human Ortholog: 9q34.1

Cellular Component: actin cytoskeleton; cytoplasm; cytosol; extrinsic to internal side of plasma membrane; nucleolus; nucleoplasm; nucleus; perinuclear region of cytoplasm

Molecular Function: actin monomer binding; ATP binding; magnesium ion binding; manganese ion binding; mitogen-activated protein kinase binding; nicotinate-nucleotide adenylyltransferase activity; non-membrane spanning protein tyrosine kinase activity; protein binding; protein C-terminus binding; protein kinase activity; protein kinase C binding; protein-tyrosine kinase activity; receptor binding; SH3 domain binding; syntaxin binding

Biological Process: actin cytoskeleton organization and biogenesis; cell cycle arrest; DNA damage induced protein phosphorylation; DNA damage response, signal transduction; DNA damage response, signal transduction resulting in induction of apoptosis; elevation of cytosolic calcium ion concentration; establishment of protein localization; innate immune response; mismatch repair; mitochondrial depolarization; mitosis; negative regulation of ubiquitin-protein ligase activity; peptidyl-tyrosine phosphorylation; positive regulation of apoptosis; positive regulation of muscle cell differentiation; positive regulation of oxidoreductase activity; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein amino acid phosphorylation; protein amino acid autophosphorylation; regulation of actin cytoskeleton organization and biogenesis; regulation of autophagy; regulation of axon extension; regulation of cell adhesion; regulation of cell proliferation; regulation of endocytosis; regulation of microtubule polymerization; regulation of transcription, DNA-dependent; response to DNA damage stimulus; response to oxidative stress

Disease: Leukemia, Chronic Myeloid

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.